The Master’s Degree in Drug Research, Development and Innovation consists of six modules with their associated subjects, for a total of 90 ECTS credits (60 for theory and practical classes and 30 for the Master's Research Project).

 

Module I (Introduction to research) includes two subjects: Research Tools, and Preclinical and Clinical Research. Through these subjects students will acquire knowledge of the basic aspects of research: scientific communication and documentation, animal experimentation and laboratory safety rules. The module also covers other knowledge concerning fundamental aspects of basic research and the development of medicines in the preclinical and clinical phases: preclinical pharmacological and toxicological studies, and clinical trials.

Module II (Quality) establishes the foundations for present-day understandings of drug quality, and how the concept has evolved and been interpreted over time. The goal is for students to be able to manage, control and assure the quality of medicines that are produced, in accordance with current law and specific requirements for the pharmaceutical industry. Students will gain the broadest possible understanding of the standards of quality assurance and quality systems implemented in the business world in general. Students will be given the information they need to perform pharmaceutical quality assurance and quality control tasks.
 

In Module III (Regulatory Affairs), students will acquire the preliminary knowledge needed to carry out the registration of a medicinal product in accordance with the requirements set out in applicable legislation. This training will leave students prepared to handle pharmaceutical development (manufacture of pilot lots, drug development, etc.) and innovation.
 

Module IV (Research management) In this module students will acquire the knowledge they need to be able to propose and manage an R&D&I activity: research project proposals and administration, protection of intellectual property rights for the results obtained, adherence to ethical principles and tracking of medicines once they are on the market.
 

Module V (Elective courses). This module offers the student a series of elective subjects, out of which 18 ECTS credits must be earned. Students may chose subjects according to their interests, their prior training or their future career direction. These subjects supplement students' training in a more specific area within the field of drug research, development and innovation.
 

Module VI (Master's Research Project) is a research project that is carried out during the course of the program, directed by a tutor who is assigned individually to each student at the start of the master's degree program. This approach allows the tutor to precisely follow the students' needs, performance, orientation and professional aspirations. This relationship can take place within the context of one of the University's departments or at a pharmaceutical company. The master's thesis project report may be prepared and presented in Spanish, in English, or in both languages.

El Máster sigue una metodología activa que combina: 

A total of 500 hours, focused on providing students with a broad theoretical foundation concerning each of the phases that comprise the development of a new drug, from its design and synthesis through its release on the market.
 

These classes are especially relevant to this master's degree program and constitute the most exhaustive part of the program. They are carried out in small groups and are specially designed to employ the most advanced techniques. Students carry out a total of 315 hours of individual laboratory work with the aim of learning the techniques used in each of the scientific fields of the program.
 

The program also seeks to introduce students to the field of applied research. To do so, students will conduct a research project within one of the lines of research carried out at CIFA, CIMA, the Clínica Universidad de Navarra, the various departments of the Schools of Sciences, Medicine or Pharmacy, or at a pharmaceutical company. During the course of the program students will devote at least 1,000 hours to their master's thesis project. 30 ECTS credits
 

Seminars are designed to provide students with the business-related training that they need in order to perform tasks involving team management, process quality assurance, scientific research administration, pharmaceutical marketing, etc. To do so, in addition to specific subjects, the program offers more than 200 hours of seminars conducted by leading professionals from pharmaceutical companies, government administrations and other universities, with the goal of sharing their experiences with candidates for the master's degree.